FDA Warning Letter — Glenmark Pharmaceuticals Inc USA
The FDA took a Warning Letter action against Glenmark Pharmaceuticals Inc USA on June 20, 2023 (Monroe, NC). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.
Action Details
- Facility
- Glenmark Pharmaceuticals Inc USA
- Date
- June 20, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Center
- CDER
- Location
- Monroe, NC (United States)